Telomerase Reverse Transcriptase p572Y (TERT572Y)
*This product has been discontinued!*
This peptide belongs to the telomerase reverse transcriptase p572Y .TERT572Y derived peptide vaccine against the non-small-cell lung cancer (NSCLC) is well tolerated and effective in eliciting a specific T cell immunity.
| RP20406 | |
|
|
|
|
|
|
| Ask us a question | |